Thalidomide for attenuation of weight loss during advanced pancreatic cancer

Thalidomide for attenuation of weight loss during advanced pancreatic cancer

Play all audios:

Loading...

Access through your institution Buy or subscribe Gordon JN _et al_. (2005) Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial. _Gut_ 54: 540–545 Profound metabolic disturbances resulting in severe muscle and fat wasting (cachexia) are significant in patients with advanced cancer. Several proinflammatory cytokines have been implicated in development of cachexia and anorexia; modulation of their effects might improve outcome in these patients. As thalidomide has been shown to downregulate the production of proinflammatory cytokines and improve cachexia associated with other conditions, its effect was investigated in this open-label, randomized, placebo-controlled trial in patients with advanced inoperable pancreatic cancer. This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support CHANGE HISTORY * _ 17 MAY 2018 This article was published with the same DOI as a previous publication. A new DOI has been assigned and registered at Crossref, and has been corrected in the article. _ RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Thalidomide for attenuation of weight loss during advanced pancreatic cancer. _Nat Rev Gastroenterol Hepatol_ 2, 206 (2005). https://doi.org/10.1038/ncponc0159x Download citation * Issue Date: 01 May 2005 * DOI: https://doi.org/10.1038/ncponc0159x SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative

Access through your institution Buy or subscribe Gordon JN _et al_. (2005) Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial. _Gut_ 54: 540–545 Profound


metabolic disturbances resulting in severe muscle and fat wasting (cachexia) are significant in patients with advanced cancer. Several proinflammatory cytokines have been implicated in


development of cachexia and anorexia; modulation of their effects might improve outcome in these patients. As thalidomide has been shown to downregulate the production of proinflammatory


cytokines and improve cachexia associated with other conditions, its effect was investigated in this open-label, randomized, placebo-controlled trial in patients with advanced inoperable


pancreatic cancer. This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and


online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes


which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support CHANGE HISTORY * _ 17 MAY 2018


This article was published with the same DOI as a previous publication. A new DOI has been assigned and registered at Crossref, and has been corrected in the article. _ RIGHTS AND


PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Thalidomide for attenuation of weight loss during advanced pancreatic cancer. _Nat Rev Gastroenterol Hepatol_ 2, 206


(2005). https://doi.org/10.1038/ncponc0159x Download citation * Issue Date: 01 May 2005 * DOI: https://doi.org/10.1038/ncponc0159x SHARE THIS ARTICLE Anyone you share the following link


with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt


content-sharing initiative